Skip to main content

What are you looking for?

Write the name, title or any keyword related to what you are looking for and select which content category it belongs to.

News

Vall d'Hebron publishes four innovative works on different systemic diseases

Articles from the Systemic Diseases research group at the VHIR focus on scleroderma, antiphospholipid syndrome, Sjögren's syndrome, and the relationship between cancer and inflammatory myopathy.

News

Ona Futura Foundation donates €40,000 for research on immune disorders related to pregnancy in Vall d’Hebron

Ona Futura Foundation has signed a donation agreement with the Vall d'Hebron Research Institute (VHIR) to contribute to research on various immune disorders related to the pregnancy process.

News

Dr. Antoni Soriano, awarded by the European Society of Paediatric Infectious Diseases (ESPID)

The VHIR researcher has been recognized for his research on the low transmissibility of COVID-19 from pediatric patients.

News

Vall d'Hebron leads a multicenter study that will assess a faster workflow for the management of patients with stroke

The international multi-centric study WE-TRUST will assess the impact of the "Direct to Angiography" approach thanks to a computed tomography technology developed and improved by Philips.

News

Una nova calculadora per predir la mortalitat en pacients amb endocarditis infecciosa podria salvar vides

L'eina està disponible online i permet ajudar a la presa de decisions mèdiques en pacients amb endocarditis infecciosa sotmesos a cirurgia cardíaca, una operació d'alt risc.

News

A new project seeks to extend nucleoside therapy to different mitochondrial disorders

CIBERER and CIBEREHD will study the possible extension of therapy based on the administration of deoxyribonucleosides to other disorders characterized by problems in the replication of mitochondrial DNA.

News

Vall d'Hebron advances in the knowledge of the biological causes of Dent's disease

The CIBBIM-Nanomedicine-Renal Pathophysiology group of the VHIR has developed renal cell models to investigate the pathophysiological mechanisms and help provide new drugs for the treatment of this disease.

News

Vall d’Hebron, UAB and UPC design an app to help assess the severity of symptoms in chronic fatigue syndrome

Researchers have shown that heart rate variability is related to the severity of fatigue in women with chronic fatigue syndrome / myalgic encephalomyelitis.

News

Vall d’Hebron participa en la creació d’un nou sistema per identificar nòduls indicadors de possibles càncers pulmonars amb Intel·ligència Artificial

Aquesta eina ha estat desenvolupada per Eurecat amb la col.laboració del Campus Vall d'Hebron coordinada pel Servei de Diagnòstic per la Imatge de l'Hospital, en el marc del projecte Deep Lung.

News

Mutua Madrileña Foundation grants two Vall d'Hebron projects

Dr. Javier Torres and Dr. Alberto Sandiumenge lead the selected works in the field of rare diseases and transplantation.

News

Two VHIR researchers have received awards at the Catalan Health Institute's 2021 Research Awards

Vall d’Hebron University Hospital hosted the Catalan Institute of Health's (ICS) Research Conference earlier today, where the 2020 and 2021 ICS Research Awards were presented.

News

Kevin Arias is awarded at the X UAB Doctoral Workshop for the invention of a simpler malaria detection device

The new device, much simpler and more immediate than current techniques, would generate results in 20 minutes and detect malaria in the most remote regions of the planet.

News

Vall d'Hebron demonstrates that the gut microbiota can facilitate the diagnosis of Crohn's disease and ulcerative colitis

The quantification of the gut microbiota, combined with clinical data, would be useful to facilitate the correct diagnosis of patients and offer them the appropriate treatment for their pathology and also to prevent the appearance of flares.

News

Vall d'Hebron demonstrates that the gut microbiota can facilitate the diagnosis of Crohn's disease and ulcerative colitis

The quantification of the gut microbiota, combined with clinical data, would be useful to facilitate the correct diagnosis of patients and offer them the appropriate treatment for their pathology and also to prevent the appearance of flares.

News

Researcher Alba Torija, awarded for the best oral communication for the analysis of the cells involved in the rejection of solid organs

The advances, led by the VHIR Nephrology group, have been presented at the XVI Congress of the Catalan Transplantation Society.

News

Vall d'Hebron and IDIAP Jordi Gol collaborate in pediatric research in primary care

The joint work has received a runner-up prize for the best Oral Communication from the Catalan Pediatric Society.

News

Endolipid Therapeutics, the spin-off of Vall d’Hebron and GENESIS Ventures, emerges to develop a new strategy to reduce visceral and subcutaneous fat

Endolipid Therapeutics has developed a new approach to reducing visceral fat with therapeutic applications to treat, for example, fatty liver, and applications will be developed to reduce subcutaneous fat.

News

Vall d'Hebron participa un any més a la Festa de la Ciència

La Festa de la Ciència tancarà aquest diumenge la Biennal Ciutat i Ciència 2021 amb un ventall d'activitats per apropar la ciència a la ciutadania. Professionals de Vall d'Hebron reflexionaran sobre telemedicina, intel.ligència artificial i càncer, i mutacions.

News

Five VHIR research projects on COVID-19 are promoted by La Marató 2020

Vall d'Hebron is the center with the most promoted projects from La Marató 2020 to research on COVID-19. Five out of the six projects are coordinated by VHIR researchers.

News

Vall d’Hebron assumes the rotating presidency of the European University Hospital Alliance (EUHA)

Dr. Albert Salazar, manager of Vall d'Hebron University Hospital, assumes for the next six months the presidency of the European University Hospital Alliance (EUHA), an alliance formed by the largest university hospitals in Europe working in collaboration to improve the outcomes of patients from tod